Comorbidities and survival in obstructive sleep apnoea beyond the age of 50

European Journal of Clinical Investigation

Volumn 43, Issue 1, 2013, Pages 27-33

  Marrone, Oreste ^a   Lo Bue, Anna ^a   Salvaggio, Adriana ^a   Dardanoni, Gabriella ^b   Insalaco, Giuseppe ^a  

^a CNR   (Italy)

^b Osservatorio Epidemiologico   (Italy)

Author keywords

Ageing; Continuous positive airway pressure; Epidemiology; Mortality; Obstructive sleep apnoea; Treatment

Indexed keywords

ADULT; APNEA HYPOPNEA INDEX; ARTERIAL OXYGEN SATURATION; ARTICLE; CARDIOVASCULAR DISEASE; CHRONIC OBSTRUCTIVE LUNG DISEASE; COMORBIDITY; DIABETES MELLITUS; FEMALE; FOLLOW UP; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD REVIEW; POLYSOMNOGRAPHY; POSITIVE END EXPIRATORY PRESSURE; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SLEEP DISORDERED BREATHING; SURVIVAL;

ADULT; AGE FACTORS; AGED; COMORBIDITY; CONTINUOUS POSITIVE AIRWAY PRESSURE; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; OXYHEMOGLOBINS; POLYSOMNOGRAPHY; REGRESSION ANALYSIS; RETROSPECTIVE STUDIES; SEVERITY OF ILLNESS INDEX; SLEEP APNEA, OBSTRUCTIVE;

EID: 84871611890     PISSN: 00142972     EISSN: 13652362     Source Type: Journal    
DOI: 10.1111/eci.12011     Document Type: Article

References (47)

1. He J, Kryger MH, Zorick FJ, Conway W, Roth T. Mortality and apnea index in obstructive sleep apnea. Experience in 385 male patients. Chest 1988;94:9-14.
2. Marin JM, Carrizo SJ, Vicente E, Agusti AG. Long-term cardiovascular outcomes in men with obstructive sleep apnoea-hypopnoea with or without treatment with continuous positive airway pressure: an observational study. Lancet 2005;365:1046-53.
3. Lavie P, Lavie L, Herer P. All-cause mortality in males with sleep apnoea syndrome: declining mortality rates with age. Eur Respir J 2005;25:514-20.
4. Young T, Finn L, Peppard PE, Szklo-Coxe M, Austin D, Nieto FJ et al. Sleep disordered breathing and mortality: eighteen-year follow-up of the Wisconsin Sleep Cohort. Sleep 2008;31:1071-8.
5. Marshall NS, Wong KKH, Liu PY, Cullen SR, Knuiman MW, Grunstein RR. Sleep apnea as an independent risk factor for all-cause mortality: the Busselton Health Study. Sleep 2008;31:1079-85.
6. Punjabi NM, Caffo BS, Goodwin JL, Gottlieb DJ, Newman AB, O'Connor GT et al. Sleep-disordered breathing and mortality: a prospective cohort study. PLoS Med 2009;6:e1000132.
7. Lavie P, Herer P, Peled R, Berger I, Yoffe N, Zomer J et al. Mortality in sleep apnea patients: a multivariate analysis of risk factors. Sleep 1995;18:149-57.
8. Marti S, Sampol G, Muñoz X, Torres F, Roca A, Lloberes P et al. Mortality in severe sleep apnoea/hypopnoea syndrome patients: impact of treatment. Eur Respir J 2002;20:1511-8.
9. Ancoli-Israel S, Klauber MR, Kripke DF, Parker L, Cobarrubias M. Sleep apnea in female patients in a nursing home. Increased risk of mortality. Chest 1989;96:1054-8.
10. Ensrud KE, Blackwell TL, Ancoli-Israel S, Redline S, Cawthon PM, Paudel ML et al. Sleep disturbances and risk of frailty and mortality in older men. Sleep Med doi: 10.1016/j.sleep.2012.04.010.
11. Bliwise DL, Bliwise NG, Partinen M, Pursley AM, Dement WC. Sleep apnea and mortality in an aged cohort. Am J Public Health 1988;78:544-7.
12. Lavie P, Lavie L. Unexpected survival advantage in elderly people with moderate sleep apnoea. J Sleep Res 2009;18:397-403.
13. Mant A, King M, Saunders NA, Pond CD, Goode E, Hewitt H. Four-year follow-up of mortality and sleep-related respiratory disturbance in non-demented seniors. Sleep 1995;18:433-8.
14. Johansson P, Alehagen U, Svanborg E, Dahlström U, Broström A. Clinical characteristics and mortality risk in relation to obstructive and central sleep apnoea in community-dwelling elderly individuals: a 7-year follow-up. Age Ageing 2012;41:468-74.
15. Ancoli-Israel S, Kripke DF, Klauber MR, Fell R, Stepnowski C, Estline E et al. Morbidity, mortality and sleep-disordered breathing in community dwelling elderly. Sleep 1996;19:277-82.
16. Partinen M, Jamieson A, Guilleminault C. Long-term outcome for obstructive sleep apnea syndrome patients. Mortality. Chest 1988;94:1200-4.
17. Veale D, Chailleux E, Hoorelbeke-Ramon A, Reybet-Degas O, Humeau-Chapuis MP, Alluin-Aigouy F et al. Mortality of sleep apnoea patients treated by nasal continuous positive airway pressure registered in the ANTADIR observatory. Eur Respir J 2000;15:326-31.
18. Campos-Rodríguez F, Peña-Griñan N, Reyes-Nuñez N, De la Cruz-Moron I, Perez-Ronchel J, De la Vega-Gallardo F et al. Mortality in obstructive sleep apnea-hypopnea patients treated with positive airway pressure. Chest 2005;128:624-33.
19. Doherty LS, Kiely JL, Swan V, McNicholas WT. Long-term effects of nasal continuous positive airway pressure therapy on cardiovascular outcomes in sleep apnea syndrome. Chest 2005;127:2076-84.
20. Campos-Rodriguez F, Martinez-Garcia MA, de la Cruz-Moron I, Almeida-Gonzalez C, Catalan-Serra P, Montserrat JM. Cardiovascular mortality in women with obstructive sleep apnea with or without continuous positive airway pressure treatment. A cohort study. Ann Intern Med 2012;156:115-22.
21. Hudgel DW, Lamerato LE, Jacobsen GR, Drake CL. Assessment of multiple health risks in a single obstructive sleep apnea population. J Clin Sleep Med 2012;8:9-18.
22. Rich J, Raviv A, Raviv N, Brietzke SE. All-cause mortality and obstructive sleep apnea severity revisited. Otolaryngol Head Neck Surg 2012;147:583-7.
23. Peker Y, Hedner J, Kraiczi H, Löth S. Respiratory disturbance index. An independent predictor of mortality in coronary artery disease. Am J Respir Crit Care Med 2000;162:81-6.
24. Lee C-H, Khoo S-M, Chan MY, Wong H-B, Low AF, Phua Q-H et al. Severe obstructive sleep apnea and outcomes following myocardial infarction. J Clin Sleep Med 2011;7:616-21.
25. Serizawa N, Yumino D, Kajimoto K, Tagawa Y, Takagi A, Shoda M et al. Impact of sleep-disordered breathing on life-threatening ventricular arrhythmia in heart failure patients with implantable cardioverter-defibrillator. Am J Cardiol 2008;102:1064-8.
26. Sahlin C, Sandberg O, Gustafson Y, Bucht G, Carlberg B, Stenlund H et al. Obstructive sleep apnea is a risk factor for death in patients with stroke: a 10-year follow-up. Arch Intern Med 2008;168:297-301.
27. Yumino D, Wang H, Floras J, Newton G, Mak S, Ruttanaumpawan P et al. Relationship between sleep apnea and mortality in patients with ischemic heart failure. Heart 2009;95:819-24.
28. Owens RL, Malhotra A. Sleep-disordered breathing and COPD: the overlap syndrome. Respir Care 2010;55:1333-46.
29. Masuda T, Murata M, Honma S, Honma S, Iwazu Y, Sasaki N et al. Sleep-disordered breathing predicts cardiovascular events and mortality in hemodialysis patients. Nephrol Dial Transplant 2011;26:2289-95.
30. Nieto FJ, Peppard PE, Young T, Finn L, Hla KM, Farré R. Sleep disordered breathing and cancer mortality: results from the Wisconsin sleep cohort study. Am J Respir Crit Care Med 2012;186:190-4.
31. Milleron O, Pillière R, Foucher A, de Roquefeuil F, Aegerter P, Jondeau G et al. Benefits of obstructive sleep apnoea treatment in coronary artery disease: a long-term follow-up study. Eur Heart J 2004;25:728-34.
32. Martínez-García L, Soler-Cataluña JJ, Ejarque-Martínez L, Soriano Y, Roman-Sanchez P, Barbè Illa F et al. Continuous positive airway pressure treatment reduces mortality in patients with ischemic stroke and obstructive sleep apnea: a 5-year follow-up study. Am J Respir Crit Care Med 2009;180:36-41.
33. Machado M-CL, Vollmer WM, Togeiro SM, Bilderback AL, Oliveira M-VC, Leitao FS et al. CPAP and survival in moderate-to-severe obstructive sleep apnoea syndrome and hypoxaemic COPD. Eur Respir J 2010;32:132-7.
34. Marin J, Soriano J, Carrizo S, Boldova A, Celli B. Outcomes in patients with chronic obstructive pulmonary disease and obstructive sleep apnea: the overlap syndrome. Am J Respir Crit Care Med 2010;182:325-31.
35. Lavie P, Herer P, Lavie L. Mortality risk factors in sleep apnoea: a matched case-control study. J Sleep Res 2007;16:28-34.
36. Young T, Finn L. Epidemiological insights into the public health burden of sleep disordered breathing: sex differences in survival among sleep clinic patients. Thorax 1998;53:S16-9.
37. Morrish E, Shneerson JM, Smith IE. Why does gender influence survival in obstructive sleep apnoea?Respir Med 2008;102:1231-6.
38. Bixler EO, Vgontzas AN, Ten Have T, Tyson K, Kales A. Effects of age on sleep apnea in men: prevalence and severity. Am J Respir Crit Care Med 1998;157:144-8.
39. Fleury B. Sleep apnea syndrome in the elderly. Sleep 1992;15:S39-41.
40. Gries RE, Brooks LJ. Normal oxyhemoglobin saturation during sleep. How low does it go?Chest 1996;110:1489-92.
41. Steiner S, Schueller PO, Schulze V, Strauer BE. Occurrence of coronary collateral vessels in patients with sleep apnea and total coronary occlusion. Chest 2010;137:516-20.
42. Tun Y, Okabe S, Hida W, Kurosawa H, Tabata M, Kikuchi Y et al. Nocturnal blood pressure during apnoeic and ventilatory periods in patients with obstructive sleep apnoea. Eur Respir J 1999;14:1271-7.
43. Krieger J, Sforza E, Boudewijns A, Zamagni M, Petiau C. Respiratory effort during obstructive sleep apnea. Role of age and sleep state. Chest 1997;112:875-84.
44. Leung RS, Comondore VR, Ryan CM, Stevens D. Mechanisms of sleep-disordered breathing: causes and consequences. Pflugers Arch 2012;463:213-30.
45. Kline CE, Crowley EP, Ewing GB, Burch JB, Blair SN, Durstine JL et al. The effect of exercise training on obstructive sleep apnea and sleep quality: a randomized controlled trial. Sleep 2011;34:1631-40.
46. Villar I, Izuel M, Carrizo S, Vicente E, Marin JM. Medication adherence and persistence in severe obstructive sleep apnea. Sleep 2009;32:623-8.
47. Platt AB, Kuna ST, Field SH, Chen Z, Gupta R, Roche DF et al. Adherence to sleep apnea therapy and use of lipid-lowering drugs: a study of the healthy-user effect. Chest 2010;137:102-8.